MARONGIU, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 362
EU - Europa 321
AS - Asia 281
SA - Sud America 4
AF - Africa 2
OC - Oceania 2
Totale 972
Nazione #
US - Stati Uniti d'America 360
IT - Italia 200
SG - Singapore 137
HK - Hong Kong 61
CN - Cina 59
DE - Germania 49
UA - Ucraina 22
KR - Corea 15
FI - Finlandia 13
CZ - Repubblica Ceca 10
FR - Francia 8
BE - Belgio 6
GB - Regno Unito 6
IL - Israele 4
SE - Svezia 3
TR - Turchia 3
AU - Australia 2
BR - Brasile 2
CA - Canada 2
LT - Lituania 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CL - Cile 1
IN - India 1
LU - Lussemburgo 1
ZA - Sudafrica 1
Totale 972
Città #
Singapore 116
Chandler 78
Hong Kong 58
Munich 30
Boardman 28
West Jordan 18
Cagliari 16
Sassari 16
Seoul 15
Princeton 14
Alghero 12
Jacksonville 12
New York 12
Helsinki 11
Dallas 10
Florence 10
Milan 10
Santa Clara 9
Romola 8
Ashburn 7
Brno 7
Wilmington 7
Ann Arbor 6
Beijing 6
Brussels 6
Dearborn 6
Nanjing 6
Rome 6
Seattle 6
Selargius 6
Hangzhou 5
Shanghai 5
Dorgali 4
Nuremberg 4
Shenzhen 4
Azzano San Paolo 3
Bologna 3
Frankfurt am Main 3
Guangzhou 3
Ningbo 3
Olomouc 3
Salerno 3
Torino 3
Agrigento 2
Albignasego 2
Città Di Castello 2
Istanbul 2
Jerusalem 2
Jiaxing 2
Lappeenranta 2
Melbourne 2
Nanchang 2
Oakland 2
Ottawa 2
Rio de Janeiro 2
Senigallia 2
Tel Aviv 2
Abidjan 1
Burgas 1
Como 1
Dalmine 1
Dubai 1
Gauteng 1
Haining 1
Hebei 1
Huzhou 1
Jiyuan 1
La Paz 1
Legnano 1
London 1
Los Angeles 1
Luxembourg 1
Padova 1
Pune 1
Quanzhou 1
Roubaix 1
Santena 1
Stockholm 1
Washington 1
Woodbridge 1
Xi'an 1
Totale 650
Nome #
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 69
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 57
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 56
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 44
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 39
Harmonization of multi-center data for preliminary investigation of cardiac MIBG scintigraphy in Parkinsonism (ITA-MIBG STUDY): a novel approach using phantom calibration with tube and bottle. 38
Brain 123I-ioflupane SPECT and 18F-FDG PET combined use in movement and cognitive associated diseases of recent appearance 34
131I-SPECT/CT after radioiodine therapy in patients with differentiated thyroid carcinoma 33
Usefulness of PET/CT with 18F-FDG in Patients with Differentiated Thyroid Carcinoma after Radioiodine Therapy: An Italian Multicenter Study 33
The role of routine 131I-SPECT/CT use in differentiated thyroid carcinoma (DTC) follow-up 28
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 27
The prognostic role of baseline and post neoadjuvant chemotherapy [18F]FDG PET/CT in triple-negative breast cancer: preliminary results of TRINE-PET trial 26
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 24
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 24
Axillary lymph node hypermetabolism (ALNH) related to COVID-19 vaccination in cancer patients undergoing 18F-FDG PET/CT: a single centre study on 500 cases 23
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 23
Hashimoto's Thyroiditis and Papillary Thyroid Carcinoma: A Follow-Up Study in Patients with Absence of Aggressive Risk Factors at the Surgery of the Primary Tumor 23
Breast-Specific Gamma Imaging: An Added Value in the Diagnosis of Breast Cancer, a Systematic Review 22
Differential Diagnosis of Alzheimer Disease vs. Mild Cognitive Impairment Based on Left Temporal Lateral Lobe Hypomethabolism on 18F-FDG PET/CT and Automated Classifiers 21
Pet-radiomics in lymphoma and multiple myeloma: update of current literature 21
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 21
First-, Second-, and Third-Generation Radiolabeled Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Positron Emission Tomography: State of the Art, a Systematic Review 20
Qualitative and semiquantitative parameters in solitary pulmonary nodule: a multicenter 18F-FDG-PET/CT study 20
Personalized Dosimetry in the Context of Radioiodine Therapy for Differentiated Thyroid Cancer 20
Prostate-Specific Membrane Antigen Radioligand Therapy in Non-Prostate Cancers: Where Do We Stand? 19
A Comparative Follow-Up Study of Patients with Papillary Thyroid Carcinoma Associated or Not with Graves' Disease 18
Complete Blood Count-Based Biomarkers as Predictors of Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients with PD-L1 < 50% Treated with First-Line Chemoimmunotherapy 17
Evaluation of Bone Scan Index as a Prognostic Tool in Breast Cancer Patients with Bone Metastasis 17
18F-FDG brain and whole body (WB) PET/CT in intracranial leptomeningeal carcinomatosis and in paraneoplastic neurologic syndromes 17
18F-FDG PET/CT (PET) and serum neurodegenerative biomarkers (NB) in suspected cognitive disorders (CD): a preliminary study 17
A multicenter study for the analysis of early onset Parkinson’s disease population: the role of 123I-FP-CIT and 123I-MIBG 17
Utility of shape and texture features from [18F]-FDG PET to predict cervical nodal status in patients with head & neck cancer 16
Prognostic role of minimal extrathyroidal tumor extension (mETE) in the follow-up of patients with papillary carcinoma (PC) unaffected by other risk factors. 16
Performance Analysis of Six Semi-Automated Tumour Delineation Methods on [18F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in Patients with Head and Neck Cancer 14
Long-term follow-up of patients thyroidectomized for thyroid papillary carcinoma (PC) with associated Graves’s disease (GD): a 131I-SPECT/CT diagnostic study 14
A multicenter 18F-FDG-PET/CT study in solitary pulmonary nodule: Qualitative and Semiquantitative parameters to predict the risk of malignancy 14
Qualitative and Semiquantitative Parameters of 18F-FDG-PET/CT as Predictors of Malignancy in Patients with Solitary Pulmonary Nodule 13
Radiomics analysis on PET/CT scans to discriminate malignant (adenocarcinoma) and benign pulmonary nodules 13
Brain SPECT DAT imaging and 18F-FDG PET/CT combined use in the early stage of movement and cognitive associated neurodegenerative disorders 13
The DASciS Software for BSI Calculation as a Valuable Prognostic Tool in mCRPC Treated with 223RaCl2: A Multicenter Italian Study 12
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 10
123I-MIBG Cardiac Scintigraphy and Heart/Mediastinum Ratio in Neurodegenerative Disorders: Is Delayed Scan Really Necessary? 10
Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study 9
Prognostic role of the risk factors in the follow-up of T1B-T2 papillary thyroid carcinoma (PC) 9
Minimal Extrathyroid Extension (mETE) as the Only Risk Factor in Patients with Papillary Thyroid Carcinoma (PC): Its Clinical Impact on Recurrence and Outcome during Long-Term Follow-Up 8
The Role of Risk Factors for the Progression of Patients with T1b-T2 Papillary Thyroid Carcinoma (PC) during Long-Term Follow-Up 5
Totale 1.044
Categoria #
all - tutte 7.576
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.576


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202036 0 0 0 0 4 5 7 2 4 8 4 2
2020/202142 4 0 4 5 13 0 5 0 5 6 0 0
2021/202243 5 2 8 0 0 2 0 3 2 2 2 17
2022/2023153 8 14 2 35 8 30 4 15 26 2 6 3
2023/2024370 42 28 9 33 94 41 0 6 1 20 26 70
2024/2025376 44 48 121 96 67 0 0 0 0 0 0 0
Totale 1.044